Inhaltspezifische Aktionen

Project 12 - Role of oxytocin in the contractility of the male reproductive tract: implications for the treatment of benign prostatic hyperplasia

Role of oxytocin in the contractility of the male reproductive tract: implications for the treatment of benign prostatic hyperplasia
Aims:
To assess the role of oxytocin in smooth muscle contractility in the prostate, contrasting this to the testis and epididymis. To develop novel oxytocin conjugates with agonistic and antagonistic function, and to test their therapeutic potential for the treatment of benign prostate hyperplasia (BPH) using our established ex vivo models.

2013 - 2017: ---

For more information please contact Betty Exintarifs or Ralf Middendorff.
Prof Dr. Ralf Middendorff

Institute of Anatomy and Cell Biology, Faculty of Medicine, JLU
Betty Exintaris, PhD

Dept of Pharmaceutical Biology, Monash University
Prof. Dr. Thomas Linn

Centre of Internal Medicine, Faculty of Medicine, JLU
Stuart Ellem, PhD

principal investigator
Sep 2017 - Dec 2017
Prof. Dr. Florian Wagenlehner

Dept of Urology, Paediatric Urology and Andrology, Faculty of Medicine, JLU
Prof. Gail Risbridger, PhD

Dept of Anatomy and Developmental Biology, Monash University
Michael Whittaker, PhD (collaborator)

Institute of Pharmaceutical Sciences, Monash University
Beatrix Stadler
Doctoral Student
2017 - to date

Institute of Anatomy and Cell Biology, Faculty of Medicine, JLU
Masroor Badshah
Doctoral Student
2019 - to date

Monash